STRATEGIC BEHAVIORAL CENTER LELAND
1. Target Overview & Investment Thesis
STRATEGIC BEHAVIORAL CENTER LELAND is a 40-bed safety-net/medicaid heavy in BRUNSWICK, NC with $19.6M in net patient revenue and a 7.4% operating margin. The hospital serves a payer mix of 27.6% Medicare, 47.3% Medicaid, and 25.1% commercial.
Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.4% to 14.7% (+736bps).
| Net Revenue HCRIS | $19.6M |
| Current EBITDA COMPUTED | $1.4M |
| Operating Margin COMPUTED | 7.4% |
| Occupancy HCRIS | 51.8% |
| Revenue / Bed COMPUTED | $490K |
| Net-to-Gross HCRIS | 42.0% |
| Distress Probability ML | 60.5% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 7.4% places it above the state median. Among 48 size-comparable peers (20-80 beds), the median margin is -3.7%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (20-80), prioritizing same-state peers. 48 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| STRATEGIC BEHAVIORAL CENTER LE (Target) | NC | 40 | $19.6M | 7.4% |
| ADVENTHEALTH HENDERSONVILLE | NC | 73 | $227.1M | -4.1% |
| THOMASVILLE MEDICAL CENTER | NC | 73 | $220.3M | -14.3% |
| BRUNSWICK COMMUNITY HOSPITAL | NC | 65 | $143.2M | 12.9% |
| LEXINGTON MEMORIAL HOSPITAL I | NC | 70 | $138.3M | 6.9% |
| WRMC HOSPITAL OPERATING CORPOR | NC | 77 | $120.6M | 0.7% |
| DAVIE MEDICAL CENTER | NC | 42 | $108.5M | 27.5% |
| NOVANT HEALTH MINT HILL MEDICA | NC | 36 | $107.8M | 9.7% |
| CAREPARTNERS REHAB HOSPITAL | NC | 74 | $96.8M | 3.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $412K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $392K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $388K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $239K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $13K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $1.4M |
| + RCM Uplift | +$1.4M |
| Pro Forma EBITDA | $2.9M |
| Current Margin | 7.4% |
| Pro Forma Margin | 14.7% |
| WC Released (1x) | $752K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $2.2M | $24.0M | 10.79x | 60.9% |
| Base (11x exit) | 10.0x | 11.0x | $2.2M | $27.1M | 12.19x | 64.9% |
| Bull Case | 9.0x | 11.0x | $2.0M | $32.6M | 16.29x | 74.7% |
| Bull (12x exit) | 9.0x | 12.0x | $2.0M | $36.1M | 18.07x | 78.4% |
| Bear Case | 11.0x | 10.0x | $2.4M | $16.0M | 6.56x | 45.7% |
| Bear (11x exit) | 11.0x | 11.0x | $2.4M | $18.4M | 7.54x | 49.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (47.3%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 60.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 48 hospitals with 20-80 beds
- Same-state prioritization (n=49)
- Comp margins: P25=-16.2% / P50=-3.7% / P75=6.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.